微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.7% | 4.48% | 877.78% | 49/71 | 2.21% | ST目药 | 9.27% | 行业排名> |
| 2024-12-31 | -0.09% | -102.04% | -104.69% | 51/71 | 3.08% | ST目药 | 22.26% | 行业排名> |
| 2024-09-30 | 1.92% | -67.95% | 23.08% | 50/71 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 1.56% | -58.84% | 132.84% | 46/71 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.67% | -67.94% | -84.84% | 55/71 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 4.42% | -37.83% | -26.21% | 43/71 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 5.99% | 1.35% | 58.05% | 42/71 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 3.79% | -3.32% | 81.34% | 42/71 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 2.09% | -30.79% | -70.6% | 44/71 | 2.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 7.11% | -21.7% | 20.3% | 35/71 | 7.39% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 5.91% | -30.8% | 50.77% | 38/71 | 5.07% | 片仔癀 | 19.69% | 行业排名> |
| 2022-06-30 | 3.92% | -31.71% | 29.8% | 35/71 | 3.13% | 片仔癀 | 12.75% | 行业排名> |
| 2022-03-31 | 3.02% | 13.96% | -66.74% | 22/71 | 2.15% | 片仔癀 | 6.88% | 行业排名> |
| 2021-12-31 | 9.08% | 25.07% | 6.32% | 27/71 | 4.45% | 片仔癀 | 27.39% | 行业排名> |
| 2021-09-30 | 8.54% | 0.12% | 48.78% | 27/71 | 7.44% | 片仔癀 | 23.14% | 行业排名> |
| 2021-06-30 | 5.74% | 37.32% | 116.6% | 22/71 | 4.61% | 片仔癀 | 13.23% | 行业排名> |
| 2021-03-31 | 2.65% | 65.63% | -63.5% | 32/71 | -2.87% | *ST长药 | 7.37% | 行业排名> |
| 2020-12-31 | 7.26% | 23.47% | -14.89% | 32/71 | -2.08% | 沃华医药 | 22.84% | 行业排名> |
| 2020-09-30 | 8.53% | 9.92% | 104.07% | 27/71 | 5.56% | 沃华医药 | 19.47% | 行业排名> |
| 2020-06-30 | 4.18% | -21.72% | 161.25% | 30/71 | 3.25% | 沃华医药 | 12.7% | 行业排名> |
| 2020-03-31 | 1.6% | -40.74% | -72.79% | 41/71 | 1.91% | 济川药业 | 7.33% | 行业排名> |
| 2019-12-31 | 5.88% | 120.22% | -24.23% | 42/71 | 3.89% | 济川药业 | 27.43% | 行业排名> |
| 2019-09-30 | 7.76% | 9.76% | 45.32% | 32/71 | 7.09% | 济川药业 | 23.05% | 行业排名> |
| 2019-06-30 | 5.34% | 7.01% | 97.78% | 26/71 | 4.58% | 济川药业 | 15.79% | 行业排名> |
| 2019-03-31 | 2.7% | 4.25% | 1.12% | 33/71 | 2.86% | 华润三九 | 10.23% | 行业排名> |
| 2018-12-31 | 2.67% | -59.48% | -62.23% | 55/71 | 7.68% | 济川药业 | 32.79% | 行业排名> |
| 2018-09-30 | 7.07% | -4.07% | 41.68% | 39/71 | 7.89% | 济川药业 | 27.55% | 行业排名> |
| 2018-06-30 | 4.99% | 10.15% | 92.66% | 31/71 | 4.92% | 济川药业 | 17.62% | 行业排名> |
| 2018-03-31 | 2.59% | 17.19% | -60.7% | 35/71 | 2.71% | 济川药业 | 10.07% | 行业排名> |
| 2017-12-31 | 6.59% | -40.79% | -10.58% | 48/71 | 9.76% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-09-30 | 7.37% | -15.19% | 62.69% | 39/71 | 8.29% | 济川药业 | 24.2% | 行业排名> |
| 2017-06-30 | 4.53% | -12.88% | 104.98% | 38/71 | 5.16% | *ST大药 | 15.31% | 行业排名> |
| 2017-03-31 | 2.21% | -5.96% | -80.14% | 36/71 | 2.6% | 济川药业 | 14.64% | 行业排名> |
| 2016-12-31 | 11.13% | -41.85% | 28.08% | 30/71 | 9.95% | 济川药业 | 7.64% | 行业排名> |
| 2016-09-30 | 8.69% | -31.41% | 67.12% | 29/71 | 9.31% | 维康药业 | 38.23% | 行业排名> |
| 2016-06-30 | 5.2% | -37.87% | 121.28% | 33/71 | 5.02% | 太极集团 | 58.41% | 行业排名> |
| 2016-03-31 | 2.35% | -34.54% | -87.72% | 35/71 | 4.04% | 新光药业 | 16.54% | 行业排名> |
| 2015-12-31 | 19.14% | -6.45% | 51.07% | 12/71 | 11.27% | 太极集团 | 71.6% | 行业排名> |
| 2015-09-30 | 12.67% | -21.35% | 51.37% | 10/71 | 8.43% | 维康药业 | 48.67% | 行业排名> |
| 2015-06-30 | 8.37% | -25.93% | 133.15% | 16/71 | 5.48% | 济川药业 | 21.37% | 行业排名> |
| 2015-03-31 | 3.59% | -21.44% | -82.45% | 23/71 | 2.93% | 贵州三力 | 15.84% | 行业排名> |